spike-protein

[ follow ]
development
www.aljazeera.com
1 year ago
Public health

China approves first domestic mRNA COVID-19 vaccine

In a study of 4,000 participants, the vaccine showed efficacy of 85.3 percent 14 to 28 days after a booster vaccination.China has approved its first domestically developed mRNA vaccine against COVID-19, its manufacturer said on Wednesday, months after the relaxation of strict zero-COVID regulations sparked a surge in cases.
the Guardian
1 year ago
Coronavirus

People who caught Covid in first wave get 'no immune boost' from Omicron

People who caught Covid during the first wave of the pandemic get no boost to their immune response if they subsequently catch Omicron, a study of triple vaccinated people reports.
moredevelopment
The IP Law Blog
1 year ago
Intellectual property law

The Battle Over the COVID-19 Vaccine Continues

I recently wrote about the patent infringement lawsuit filed by Moderna against Pfizer/BioNTech over the COVID-19 vaccine.In its complaint filed in federal district court in Boston last August, Moderna alleged that Pfizer/BioNTech infringed three of Moderna's patents in developing the Pfizer/BioNTech COVID-19 vaccine.
Ars Technica
1 year ago
OMG science

As COVID vaccine patent dispute drags on, Moderna forks over $400M to NIH

Vaccine maker Moderna has forked over $400 million to the National Institutes of Health for using a molecular stabilizing technique borrowed from government and academic researchers in its mRNA-based COVID-19 vaccine-which the company made roughly $36 billion selling amid the deadly pandemic, according to The New York Times.
Ars Technica
1 year ago
Public health

Nasal COVID vaccine blows clinical trial, flinging researchers back to the lab

The nasal version of the Oxford/AstraZeneca COVID-19 vaccine failed an early-stage clinical trial, dashing hopes for better infection prevention and forcing researchers to re-think the design.
Boston.com
1 year ago
Boston

How to protect yourself from BA.5, according to BMC, Brigham and Women's doctors

"We have more knowledge and we have more measures now. We know that a layered approach is how we get to the other side."
www.npr.org
2 years ago
Health

When 2 coronavirus variants meet inside 1 person, a Frankenstein hybrid can be born

On February 16, Scott Nguyen went hunting.
And what he found is a bit surprising: a coronavirus variant that looks like a Frankenstein virus.
Nytimes
2 years ago
World politics

Kids, Covid Isolation and Learning to Endure

SYDNEY, Australia - We're binge-buying rapid antigen tests for immediate delivery.We get all our food left at the front door and keep masks in every room.
www.independent.co.uk
1 year ago
UK news

Moderna, Pfizer and BioNTech Covid vaccine patent dispute heads to 2024 trial

A High Court battle between rival developers of Covid-19 jabs over patents for vaccine technology is set to be heard in London next year.Pharmaceutical giant Pfizer and drug manufacturer BioNTech are locked in a dispute with vaccine maker Moderna over the use of messenger RNA (mRNA) technology in coronavirus jabs, with similar litigation taking place in the US, Germany and the Netherlands.
www.npr.org
1 year ago
Science

How monoclonal antibodies lost the fight with new COVID variants

Antonio Rapuano got an infusion of a monoclonal antibody to treat his COVID in Albano, Italy in 2021.Such infusions have been effective treatments for COVID during the pandemic, but doctors are now finding that most monoclonal antibodies no longer work against new variants of SARS-CoV-2.Yara Nardi/Reuters Monoclonal antibodies were once the star of COVID-19 outpatient treatments.
Towleroad Gay News
1 year ago
Public health

Moderna Sues Pfizer, BioNTech For Covid-19 Vaccine Patent Infringement - Towleroad Gay News

Moderna has launched lawsuits against Pfizer and its partner BioNTech over coronavirus vaccine technology Washington (AFP) - Moderna said Friday it is suing rival vaccine makers Pfizer and BioNTech, alleging the partners infringed on its patents in developing their Covid-19 shot administered to hundreds of millions around the world.
www.aljazeera.com
1 year ago
Public health

Moderna sues rival COVID-19 vaccine makers Pfizer and BioNTech

Moderna previously pledged not to enforce COVID-19-related patents but changed its stance as the pandemic shifted gears.
time.com
1 year ago
Public health

Moderna Sues Pfizer Over Patents Behind COVID-19 Vaccine

COVID-19 vaccine maker Moderna is suing Pfizer and the German drugmaker BioNTech, accusing its main competitors of copying Moderna's technology in order to make their own vaccine.
the Guardian
1 year ago
Public health

UK scientists take 'promising' step towards single Covid and cold vaccine

Scientists have made a "promising" advance towards developing a universal coronavirus vaccine to tackle Covid-19 and the common cold.
www.cnn.com
1 year ago
Health

Updated boosters are cutting the risk of getting sick from Covid-19 by about half

The updated Covid-19 boosters are cutting the risk that a person will get sick from the coronavirus by about half, even against infections caused by the rapidly spreading XBB.1.5subvariant.New studies, conducted by researchers at the US Centers for Disease Control and Prevention, are among the first looks at how the bivalent boosters have continued to work in the real world as the virus has evolved.
www.cnn.com
1 year ago
Health

Baby whose parents refused blood from vaccinated donors undergoes lifesaving heart surgery

A six-month-old baby whose parents refused to allow him to undergo lifesaving heart surgery using blood from people vaccinated against Covid-19 has been operated on in a New Zealand hospital.Earlier this week, a judge ruled that the boy, who cannot be identified for legal reasons, would remain under the court's guardianship until he had recovered from the surgery.
www.bostonherald.com
1 year ago
Health

Boston University COVID researchers combine omicron spike protein with original virus, test strain on mice

Boston University COVID researchers have combined the omicron variant spike protein with the original virus, testing the created strain on mice to help fight against future pandemics, according to BU.
www.npr.org
1 year ago
Health

Advisers to the FDA back Novavax COVID vaccine

Dr. Stephaun Wallace, who leads the global external relations strategies for the COVID-19 Prevention Network at the Fred Hutchinson Cancer Research Center in Seattle, receives his second injection from Dr. Tia Babu during the Novavax vaccine phase 3 clinical trial in February 2021.
www.npr.org
1 year ago
Health

Is it time for a reality check on rapid COVID tests?

Rapid antigen tests are ubiquitous, but some Americans have learned the hard way that a negative test result isn't necessarily the final word.Mahmoud Illean/AP As the COVID-19 pandemic enters its fourth year, a negative result on a little plastic at-home test feels a bit less comforting than it once did.
www.verifythis.com
1 year ago
Coronavirus

No, Boston University didn't create a COVID strain with a human mortality rate of 80%

Researchers at Boston University have come under fire on social media in recent weeks over claims about a lab-made coronavirus strain.Some people on social media have claimed that the university made a new strain with an 80% human mortality rate.Why are scientists developing a new lethal COVID strain that would kill 80% of people infected?
Boston.com
1 year ago
Boston

Here's what BU is saying about media coverage of its work with a hybrid COVID virus

"They've sensationalized the message, they misrepresent the study and its goals in its entirety."
Boston.com
1 year ago
Boston

Researchers at Boston hospitals may have found a biomarker for long COVID

The marker, found in blood samples, could help doctors identify people with long COVID who are most likely to benefit from new treatment.
www.cnn.com
1 year ago
Health

CDC advisers recommend Novavax Covid-19 vaccine for adults

Vaccine advisers to the US Centers for Disease Control and Prevention voted 12-0 Tuesday to recommend Novavax's Covid-19 vaccine for use as a two-dose primary series in adults.
calgaryherald
1 year ago
Coronavirus

COVID-19 Update: North Korea reports first death due to COVID | Biden marks 1 million Americans dead from COVID

Watch this page throughout the day for updates on COVID-19 in Calgary
...
North Korea reports first COVID-19 death after 350,000 sickened with fever
IPWatchdog.com | Patents & Patent Law
1 year ago
Intellectual property law

NIH Makes Deal with WHO to Share Key COVID Technologies

"The United States will finally share some of the publicly funded innovations needed to produce COVID-19 vaccines with the world.But this is just a first step.
Slate Magazine
2 years ago
Public health

What's Actually Going On With the Scary-Sounding New COVID Variant, "Deltacron"

Admittedly, I went through all five stages of grief when I first saw a reference to"deltacron," a coronavirus variant.Another one?
time.com
1 year ago
Wellness

Is It Easier to Get COVID-19 Outdoors with BA.5?

When the pandemic first began, COVID-19 seemed to lurk around every corner, so it came as a big relief when scientists established that the virus doesn't easily spread outdoors.
Ars Technica
1 year ago
OMG science

BA.4, BA.5 gain ground in US, pose higher risk of breakthrough infections

Omicron subvariant BA.2.12.1 has overtaken BA.2 as the dominant version of the pandemic coronavirus in the US, now accounting for an estimated 59 percent of cases nationwide.
Ars Technica
2 years ago
OMG science

Researchers may have ID'ed first deer-to-human SARS-CoV-2 transmission

Covid-19 Coverage
www.aljazeera.com
2 years ago
Public health

Moderna signs MOU with Kenya for first mRNA facility in Africa

Published On 8 Mar 20228 Mar 2022 Pharmaceutical giant Moderna has signed a memorandum of understanding (MOU) with Kenya's government for its first mRNA vaccine manufacturing facility in Africa.
Washington Post
2 years ago
Business

Analysis | Joe Biden Made Lots of Covid-19 Promises. Can He Keep Them?

Covid-19 has been pushed off front pages by falling case counts and other news stories, though the pandemic's threat hasn't really changed - we're just in the trough of the last wave.
[ Load more ]